Regulator

EMA

Monitor European Medicines Agency pharmacovigilance and regulatory intelligence: PRAC signal assessments, EudraVigilance monitoring expectations under EU GVP, product information updates, and centrally authorised product safety actions. Each briefing maps EMA developments to workflows such as signal validation, label governance, and QPPV oversight.

1 update · Sorted by impact priority

publicEuropean Medicines Agency (EMA) · European Union · Updated Jun 5, 2026

EMA/HMA Workshop Recommendations on Mechanistic Model Reporting and Qualification

Urgency: Low

Review updated EMA guidance on mechanistic model reporting and qualification when published; align sponsor submissions with new qualification pathways and reporting requirements for MIDD and safety-related models.

Signal ManagementRegulatory Intelligence Lead

SOP Impact1 SOPs

ConfidenceHigh

Relevant for: Regulatory Intelligence Lead, Signal Management Lead

verifiedRegulatory action: Report

Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only